| Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease PR Gajjala, D Fliser, T Speer, V Jankowski, J Jankowski Nephrology Dialysis Transplantation 30 (11), 1814-1824, 2015 | 134 | 2015 |
| Cellular and molecular mechanisms of chronic kidney disease with diabetes mellitus and cardiovascular diseases as its comorbidities PR Gajjala, M Sanati, J Jankowski Frontiers in immunology 6, 340, 2015 | 116 | 2015 |
| Disposition and clinical implications of protein-bound uremic toxins J Jansen, J Jankowski, PR Gajjala, JFM Wetzels, R Masereeuw Clinical science 131 (14), 1631-1647, 2017 | 53 | 2017 |
| Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites M Rueth, HD Lemke, C Preisinger, D Krieter, W Theelen, P Gajjala, ... Acta Physiologica 215 (1), 13-23, 2015 | 52 | 2015 |
| Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration F Böhringer, V Jankowski, PR Gajjala, W Zidek, J Jankowski ASAIO journal 61 (1), 55-60, 2015 | 50 | 2015 |
| Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis PR Gajjala, RK Kasam, D Soundararajan, D Sinner, SK Huang, AG Jegga, ... JCI insight 6 (20), e152503, 2021 | 49 | 2021 |
| New therapeutics based on emerging concepts in pulmonary fibrosis V Sontake, PR Gajjala, RK Kasam, SK Madala Expert opinion on therapeutic targets 23 (1), 69-81, 2019 | 34 | 2019 |
| Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma PR Gajjala, V Jankowski, G Heinze, G Bilo, A Zanchetti, H Noels, E Liehn, ... Hypertension 70 (2), 412-419, 2017 | 27 | 2017 |
| Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach PR Gajjala, H Bruck, H Noels, G Heinze, F Ceccarelli, A Kribben, ... Journal of Molecular Medicine 97, 1451-1463, 2019 | 17 | 2019 |
| Fibrocyte accumulation in the lungs of cystic fibrosis patients RK Kasam, PR Gajjala, AG Jegga, JA Courtney, SH Randell, EL Kramer, ... Journal of Cystic Fibrosis 19 (5), 815-822, 2020 | 11 | 2020 |
| Notch3: a New culprit in fibrotic lung disease PR Gajjala, SK Madala American Journal of Respiratory Cell and Molecular Biology 64 (4), 403-404, 2021 | 8 | 2021 |
| NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis A Parolia, S Eyunni, BK Verma, E Young, Y Liu, L Liu, J George, S Aras, ... Nature Genetics 56 (10), 2132-2143, 2024 | 7 | 2024 |
| Wilms Tumor 1-Driven Fibroblast Activation and Subpleural Thickening in Idiopathic Pulmonary Fibrosis PR Gajjala, P Singh, V Odayar, HH Ediga, FX McCormack, SK Madala International Journal of Molecular Sciences 24 (3), 2850, 2023 | 2 | 2023 |
| Discovery of the first selective and potent PROTAC degrader for the pseudokinase TRIB2 C Wen, PR Gajjala, Y Liu, B Chen, MS Bal, P Sutaria, Q Yuanyuan, ... European Journal of Medicinal Chemistry 281, 117016, 2025 | | 2025 |
| Abstract A055: NSD2 is a requisite and targetable subunit of the AR/FOXA1 neo-enhanceosome complex in prostate cancer cells A Parolia, BK Verma, S Eyunni, S Aras, SE Carson, E Young, CK Das, ... Cancer Research 83 (11_Supplement), A055-A055, 2023 | | 2023 |
| Dysregulated Sox9 Overexpression in Multiple Lung Cells Contributes to Severe Fibrotic Lung Disease P Singh, PR Gajjala, HH Ediga, CP Vemulapalli, V Sontake, S Shambhu, ... A65. THE ALVEOLAR NICHE IN THE SPOTLIGHT OF LUNG FIBROSIS, A2189-A2189, 2023 | | 2023 |
| SOX9 Is a Positive Regulator of Fibroblast Activation in Idiopathic Pulmonary Fibrosis PR Gajjala, D Soundararajan, RK Kasam, D Sinner, SK Huang, A Jegga, ... TP115. TP115 FIBROSIS: FIBROBLAST/MYOFIBROBLAST ACTIVATION, A4406-A4406, 2021 | | 2021 |
| Aberrant Upregulation of SOX9 by Distal Lung Mesenchymal Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis P Gajjala, RK Kasam, D Soundararajan, D Sinner, N Gupta, A Jegga, ... D27. CELLULAR RESPONSES INFORMING LUNG REPAIR, A6386-A6386, 2020 | | 2020 |
| Human plasma proteomics for the identification of novel substances involved in the pathogenesis of chronic kidney disease using mass spectrometric approach PR Gajjala, J Jankowski, G Pradel Fachgruppe Biologie, 2018 | | 2018 |
| A PROTEO-BIOSTATISTIC APPROACH FOR FINDING THE UNDERLYING MOLECULAR DETERMINANTS OF HYPERTENSION PR Gajjala, V Jankowski, G Heinze, G Bilo, A Zanchetti, J Jankowski NEPHROLOGY DIALYSIS TRANSPLANTATION 32, 119-+, 2017 | | 2017 |